Trial Profile
An Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Warfarin (Primary)
- Indications Overactive bladder; Thrombosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 28 Jun 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 10 Mar 2009 New trial record